Skip to content
Nonprofiteer
← DIABETES RESEARCH INSTITUTE FOUNDATION INC

Form 990 for tax year 2022

Filed by DIABETES RESEARCH INSTITUTE FOUNDATION INC.

Totals

Total revenue
$7,129,662
Total expenses
$11,554,214
Contributions and grants received
$3,261,763
Grants paid
$5,209,284
Program service revenue
$0
Investment income
$1,344,179
Other revenue
$2,523,720
Total assets, end of year
$28,164,828
Total liabilities, end of year
$799,974
Net assets or fund balances, end of year
$27,364,854
Program services expenses (Part IX)
$6,907,088
Management and general expenses
$2,071,601
Fundraising expenses
$2,575,525
Program service expenses (Part III)
$6,907,088

Program services were 59.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $3,261,763

  • 1g · Noncash contributions included above

    $50,762

  • 3 · Investment income

    total $737,942 · excluded $737,942

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 6d · Net rental income or loss

    total $0

  • 7a · Gross sales of assets other than inventory

    securities $4,976,717

  • 7b · Less cost or other basis and sales expenses

    securities $4,370,480

  • 7c · Gain or loss

    securities $606,237

  • 7d · Net gain or loss

    total $606,237 · excluded $606,237

  • 8a · Fundraising events: gross income

    $5,010,196

  • 8b · Fundraising events: direct expenses

    $2,486,476

  • 8c · Net income from fundraising events

    total $2,523,720 · excluded $2,523,720

  • 9a · Gaming: gross income

    $0

  • 9b · Gaming: direct expenses

    $0

  • 9c · Net income from gaming

    total $0

  • 10a · Gross sales of inventory

    $0

  • 10b · Cost of goods sold

    $0

  • 10c · Net income from sales of inventory

    total $0

  • 11e · Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $5,209,284 · program services $5,209,284

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $588,582 · program services $157,497 · management and general $153,175 · fundraising $277,910

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $2,611,137 · program services $920,786 · management and general $497,068 · fundraising $1,193,283

  • 8 · Pension plan contributions

    total $105,170 · program services $7,330 · management and general $23,715 · fundraising $74,125

  • 9 · Other employee benefits

    total $206,418 · program services $1,451 · management and general $81,775 · fundraising $123,192

  • 10 · Payroll taxes

    total $158,955 · program services $9,562 · management and general $54,822 · fundraising $94,571

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $13,644 · program services $0 · management and general $10,994 · fundraising $2,650

  • 11c · Fees: accounting

    total $102,232 · program services $0 · management and general $102,232 · fundraising $0

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $187,037 · management and general $187,037

  • 11g · Fees: other

    total $395,664 · program services $99,074 · management and general $126,336 · fundraising $170,254

  • 12 · Advertising and promotion

    total $151,951 · program services $149,051 · management and general $50 · fundraising $2,850

  • 13 · Office expenses

    total $201,447 · program services $3,069 · management and general $29,159 · fundraising $169,219

  • 14 · Information technology

    total $61,716 · program services $1,243 · management and general $57,488 · fundraising $2,985

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $248,813 · program services $15,355 · management and general $203,587 · fundraising $29,871

  • 17 · Travel

    total $64,219 · program services $4,081 · management and general $6,718 · fundraising $53,420

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $1,155 · program services $150 · fundraising $1,005

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $116,718 · program services $4,018 · management and general $105,644 · fundraising $7,056

  • 23 · Insurance

    total $45,585 · management and general $45,585

  • 24a · Other expenses: CONTRACTUAL SERVICES

    total $572,191 · program services $163,391 · management and general $73,172 · fundraising $335,628

  • 24b · Other expenses: PRINTING AND GRAPHICS

    total $301,697 · program services $12,595 · management and general $1,960 · fundraising $287,142

  • 24c · Other expenses: MERCHANT FEES

    total $52,633 · management and general $52,633

  • 24d · Other expenses: DUES AND SUBSCRIPTIONS

    total $39,319 · program services $7,475 · management and general $2,387 · fundraising $29,457

  • 24e · All other expenses

    total $118,647 · program services $141,676 · management and general $256,064 · fundraising -$279,093

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $2,870,808 · end of year $3,061,074

  • 2 · Savings and temporary cash investments

    beginning of year $0 · end of year $0

  • 3 · Pledges and grants receivable

    beginning of year $3,251,526 · end of year $1,804,835

  • 4 · Accounts receivable

    beginning of year $305,202 · end of year $0

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $0 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $0 · end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $0 · end of year $921,080

  • 10a · Land, buildings and equipment: cost or other basis

    $649,037

  • 10b · Land, buildings and equipment: accumulated depreciation

    $667,206

  • 10c · Land, buildings and equipment, net

    beginning of year $122,965 · end of year -$18,169

  • 11 · Investments: publicly traded securities

    beginning of year $24,863,725 · end of year $22,315,075

  • 12 · Investments: other securities

    beginning of year $0 · end of year $0

  • 13 · Investments: program-related

    beginning of year $0 · end of year $0

  • 14 · Intangible assets

    beginning of year $0 · end of year $0

  • 15 · Other assets

    beginning of year $830,411 · end of year $80,933

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,373,041 · end of year $799,974

  • 18 · Grants payable

    beginning of year $0 · end of year $0

  • 19 · Deferred revenue

    beginning of year $0 · end of year $0

  • 20 · Tax-exempt bond liabilities

    beginning of year $0 · end of year $0

  • 21 · Escrow or custodial account liability

    beginning of year $0 · end of year $0

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $0 · end of year $0

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $0

  • 25 · Other liabilities

    beginning of year $0 · end of year $0

  • 27 · Net assets without donor restrictions

    beginning of year $10,080,546 · end of year $6,573,804

  • 28 · Net assets with donor restrictions

    beginning of year $20,791,050 · end of year $20,791,050

Mission and programs · 2022

Mission

TO PROVIDE THE DIABETES RESEARCH INSTITUTE WITH THE FUNDING TO CURE DIABETES NOW.

  • THE DIABETES RESEARCH INSTITUTE FOUNDATION FUNDS BASIC, PRE-CLINICAL AND PATIENT-BASED RESEARCH STUDIES, INCLUDING FIVE PHASE I/II CLINICAL STUDIES, SEVERAL OF WHICH ARE SIMULTANEOUSLY UNDERWAY AT THE DIABETES RESEARCH INSTITUTE (DRI), WITH THE OTHERS PENDING COMMENCEMENT. THE ONGOING 'ISLETS IN THE OMENTUM' BIOHUB TRIAL WAS THE FIRST STEP IN TESTING THE SAFETY AND EFFICACY OF INSULIN-PRODUCING CELLS TRANSPLANTED WITHIN A TISSUE-ENGINEERED PLATFORM IN A DIFFERENT SITE THAN THE LIVER, THE TRADITIONAL TRANSPLANT SITE. FOUNDATION FUNDING HAS ALLOWED THE DRI'S CLINICAL CELL TRANSPLANT TEAM TO CONTACT AND SCREEN MORE THAN 1,200 CANDIDATES FOR THIS INNOVATIVE PILOT TRIAL, SEVERAL OF WHOM WERE SELECTED AND PLACED ON THE WAITING LIST TO UNDERGO THE PROCEDURE PENDING THE AVAILABILITY OF A MATCHING DONOR ORGAN. OTHER ALTERNATIVE TRANSPLANT SITES CONTINUE TO BE EXPLORED. DRIF FUNDING ALSO SUPPORTS THE CONTINUED FOLLOW-UP AND CARE OF THE DRI'S ISLET TRANSPLANT PATIENTS WHO HAVE PARTICIPATED IN PREVIOUS CLINICAL TRIALS. MANY OF THESE HAVE REMAINED INSULIN INDEPENDENT FOR A VARYING NUMBER OF YEARS. THIS PAST YEAR, DRI PRESENTED DATA SHOWING THAT THEIR ISLET TRANSPLANT PATIENTS WHO WERE STILL FREE FROM INSULIN FOR AN AVERAGE OF 10 YEARS HAD NEAR-NORMAL BLOOD SUGAR LEVELS, SIMILAR TO THOSE WITHOUT DIABETES. DRIF HAS ALSO FUNDED DRI RESEARCH PROJECTS THAT FOCUS ON ESTABLISHING IMMUNE TOLERANCE AND REVERSING AUTOIMMUNITY, THE BODY'S DESTRUCTION OF THE INSULIN-PRODUCING CELLS WHICH CAUSED THE ONSET OF THE DISEASE. SEVERAL OF THE CLINICAL TRIALS ADDRESS THESE CHALLENGES WHILE OTHER RESEARCH EARLIER IN THE PIPELINE REMAINS UNDERWAY. ANOTHER MAJOR RESEARCH AREA THAT DRIF SUPPORTS IS THE DEVELOPMENT OF AN UNLIMITED SUPPLY OF INSULIN-PRODUCING CELLS. DRIF-FUNDED STUDIES HAVE LED TO SIGNIFICANT PROGRESS IN STIMULATING THE REGENERATION OF PANCREATIC STEM CELLS INTO INSULIN-PRODUCING CELLS USING A SINGLE FDA-APPROVED MOLECULE. THIS SIGNIFICANT FINDING OPENS TO DOOR TO A NATURAL CELL SUPPLY BANK WITHIN THE PATIENT'S BODY, ADDRESSING SEVERAL ONGOING CHALLENGES FOR CURING THE DISEASE. THE DRIF HAS FUNDED INTERNATIONAL RESEARCHER TRAINING AND KEY COLLABORATIVE PROGRAMS THAT HELP ACCELERATE RESEARCH PROGRESS THROUGH THE SHARING OF IDEAS AND ADVANCEMENTS. ALSO, DRIF-FUNDED RESEARCH EQUIPMENT WAS USED IN A PHASE III MULTI-CENTER CLINICAL ISLET TRANSPLANTATION TRIAL. THE RESULTING DATA DEMONSTRATED THAT ISLET TRANSPLANTATION IS EFFECTIVE IN PREVENTING SEVERE HYPOGLYCEMIA - DANGEROUSLY LOW BLOOD SUGAR LEVELS - WHICH REPRESENTS A PARTICULARLY FEARED COMPLICATION IN TYPE 1 DIABETES THAT CAN LEAD TO SEIZURES, LOSS OF CONSCIOUSNESS AND EVEN DEATH. IMPORTANTLY, THE RESULTS OF THIS PHASE III TRIAL PAVE THE WAY FOR ISLET TRANSPLANTATION TO BECOME AN FDA-APPROVED TREATMENT FOR PATIENTS WITH DIABETES AND ONE THAT WOULD BE ELIGIBLE FOR INSURANCE REIMBURSEMENT. KEY FUNDED RESEARCH AREAS INCLUDE CELL-BASED THERAPIES FOR ISLET REPLACEMENT, IMMUNE TOLERANCE, IMMUNE REGULATION, REGENERATIVE MEDICINE, AND STEM CELL RESEARCH, AMONG OTHERS, TO RESTORE BIOLOGICAL INSULIN PRODUCTION. TOGETHER WITH OTHER DIABETES ADVOCACY ORGANIZATIONS, THE DRIF HAS APPEARED BEFORE CONGRESS TO REQUEST INCREASED FUNDING FOR DIABETES RESEARCH, AND HAS MADE RECOMMENDATIONS ON THE FUTURE DIRECTION OF RESEARCH APPROPRIATIONS. DRIF ALSO HOSTS AND PARTICIPATES IN A VARIETY OF INFORMATIONAL WORKSHOPS FOR PEOPLE WITH DIABETES AND THEIR FAMILIES FOCUSING ON THE LATEST ADVANCES TOWARD A CURE AND THE NEWEST DIABETES MANAGEMENT TECHNIQUES. THROUGH ITS WEBSITE DIABETESRESEARCH.ORG, THE DRIF PROVIDES 'NEWS YOU CAN USERESEARCH UPDATES FOR THOSE LIVING WITH DIABETES AND THEIR FAMILY MEMBERS IN THE FORM OF E-NEWSLETTERS, VIDEOS, EMAIL ANNOUNCEMENTS AND INFORMATION VIA SOCIAL MEDIA.

    Expenses $6,249,645 · Grants $5,209,284

  • COMMUNITY DIABETES EDUCATION. THE DIABETES RESEARCH INSTITUTE FOUNDATION PROVIDES INFORMATION TO THE PUBLIC VIA ITS WEBSITE LITERATURE, SPEAKERS AND HOSTING AN ANNUAL DIABETES RESEARCH CONFERENCE, PRINT INTERVIEWS AND TOLL FREE NUMBER 800-321-3437. THE PUBLIC GAINS KNOWLEDGE ABOUT DIABETES, DIABETES CARE AND RESEARCH TOWARDS FINDING A CURE FOR DIABETES.

    Expenses $657,443

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Sean Kramer

    CHIEF EXECUTIVE OFFICER

    Total calculated
    $251,642
    From this org
    $237,501
    From related orgs
    $0
    Other
    $14,141
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $237,501
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $14,141
    Filer's total
    $251,642
  • Amy Powers

    CHIEF DEVELOPMENT OFFICER

    Total calculated
    $235,322
    From this org
    $208,322
    From related orgs
    $0
    Other
    $27,000
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $208,322
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $27,000
    Filer's total
    $235,322
  • Jill Shapiro-Miller

    EXECUTIVE VICE PRESIDENT

    Total calculated
    $224,952
    From this org
    $197,952
    From related orgs
    $0
    Other
    $27,000
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $197,952
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $27,000
    Filer's total
    $224,952
  • Thomas Karlya

    EXECUTIVE VICE PRESIDENT

    Total calculated
    $210,372
    From this org
    $197,952
    From related orgs
    $0
    Other
    $12,420
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $197,952
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $12,420
    Filer's total
    $210,372
  • Samantha Davis

    CHIEF FINANCIAL OFFICER

    Total calculated
    $151,470
    From this org
    $142,759
    From related orgs
    $0
    Other
    $8,711
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $142,759
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $8,711
    Filer's total
    $151,470
  • Jessica Sinnes

    ASSISTANT VP, PHILANTHROPY

    Total calculated
    $140,095
    From this org
    $122,890
    From related orgs
    $0
    Other
    $17,205
    Hours/week
    50
  • Stephanie Lanza

    DIRECTOR STRATEGIC PARTNERSHIP

    Total calculated
    $134,733
    From this org
    $122,228
    From related orgs
    $0
    Other
    $12,505
    Hours/week
    50
  • MacKenzie Crane

    DIRECTOR OF MAJOR GIFTS

    Total calculated
    $123,872
    From this org
    $116,822
    From related orgs
    $0
    Other
    $7,050
    Hours/week
    50
  • William Fishlinger

    BOARD CHAIRMAN

    Total calculated
    $0
    Hours/week
    5
  • John Doscas

    VICE CHAIRMAN

    Total calculated
    $0
    Hours/week
    5
  • Harold Doran Jr

    IMMEDIATE PAST BOARD CHAIRMAN

    Total calculated
    $0
    Hours/week
    5
  • Bruce Siegel

    TREASURER

    Total calculated
    $0
    Hours/week
    5
  • Matthew Stubbs

    SECRETARY

    Total calculated
    $0
    Hours/week
    5
  • Marc S Goodman

    AT LARGE

    Total calculated
    $0
    Hours/week
    5
  • Charles Rizzo

    AT LARGE

    Total calculated
    $0
    Hours/week
    5
  • Marlene Berg

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Ronald Darling

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Marc Goldfarb

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Esther Goodman

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Bonnie Inserra

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Lindsey Inserra-Hughes

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Eleanor Kosow

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Scarlett Leung

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Ramon Poo

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Stephen Rizzo

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Ricardo Salmon

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Sam Talbot

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Richard Tonkinson

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Jill Viner

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Bruce Waller

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • DIABETES RESEARCH INSTITUTE UK

    501(C)(3) · DONATIONS · UK · controlled entity

    Directly controlled by DRIF

Provenance

Return type
form_990
Tax year
2022
Filed
30 April 2024
IRS schema version
2022v5.0
Source object
202411359349301511

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.